## Ketone Body Metabolism: Synthesis and Utilization ### Overview of Ketone Body Production **Key Point:** Ketone bodies are produced primarily in the liver but also in small amounts in the kidney cortex and small intestine during prolonged fasting and metabolic stress. The statement that ketone bodies are produced "exclusively" in the liver is incorrect. While the liver is the major site of ketogenesis, the kidney cortex and small intestine can also synthesize ketone bodies, particularly during prolonged fasting or in diabetic ketoacidosis. ### Correct Statements Analyzed **Option 1 — Acetoacetyl-CoA Thiophorase (Correct)** - This enzyme (also called 3-ketoacyl-CoA transferase or succinyl-CoA transferase) catalyzes the first step of ketone body utilization in extrahepatic tissues - Reaction: Acetoacetate + Succinyl-CoA → Acetoacetyl-CoA + Succinate - This is a crucial step because the liver lacks this enzyme, preventing hepatic utilization of its own ketone bodies **Option 3 — β-Hydroxybutyrate Predominance (Correct)** - β-Hydroxybutyrate comprises ~70% of circulating ketone bodies - It is the reduced form: Acetoacetate + NADH + H⁺ ↔ β-Hydroxybutyrate + NAD⁺ - The ratio of β-hydroxybutyrate to acetoacetate reflects the NADH/NAD⁺ ratio in hepatic mitochondria **Option 4 — Extrahepatic Utilization (Correct)** - Brain: Uses ketone bodies as 60–70% of energy during prolonged fasting - Heart: Preferentially oxidizes ketone bodies over glucose - Kidney cortex: Significant consumer of ketone bodies - Skeletal muscle: Minor consumer (primarily during extreme starvation) ### Why Option 2 Is Wrong **High-Yield:** The kidney cortex and small intestine are secondary sites of ketogenesis. This becomes clinically significant in: - Prolonged fasting (>3 days): Renal contribution increases to ~40% of total ketone body production - Diabetic ketoacidosis: Enhanced gluconeogenesis in kidney also increases ketogenesis - Post-absorptive state: Small intestine contributes via glutamine metabolism The word "exclusively" makes this statement factually incorrect. ### Ketogenesis Pathway Summary ```mermaid flowchart TD A[Fatty Acid β-oxidation]:::action --> B[Acetyl-CoA]:::outcome B --> C[Acetoacetyl-CoA]:::action C --> D[HMG-CoA]:::action D --> E[Acetoacetate]:::outcome E --> F[β-Hydroxybutyrate]:::outcome E --> G[Acetone]:::outcome F --> H[Extrahepatic tissues]:::action H --> I[Acetoacetyl-CoA via thiophorase]:::action I --> J[Acetyl-CoA for TCA cycle]:::action K[Liver mitochondria]:::decision L[Kidney cortex]:::decision M[Small intestine]:::decision K --> A L --> A M --> A ``` **Clinical Pearl:** In diabetic ketoacidosis, the ratio of β-hydroxybutyrate to acetoacetate is markedly elevated (up to 10:1) due to the extremely high NADH/NAD⁺ ratio in hepatic mitochondria, reflecting intense fatty acid oxidation. **Mnemonic — Three Ketone Bodies:** **BAA** = β-hydroxybutyrate, Acetoacetate, Acetone (though acetone is not metabolized further and is exhaled).
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.